Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 56.42
+1.24 (2.25%)
Jun 17, 2026, 2:35 PM CST
SHA:688336 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,974 | 2,899 | 704.58 | 294.61 | 49.3 | 18.06 |
Depreciation & Amortization | 123.47 | 123.47 | 127.97 | 96.08 | 122.41 | 135.46 |
Other Amortization | 0.36 | 0.36 | - | - | - | - |
Loss (Gain) From Sale of Assets | 1.09 | 1.09 | -0.12 | -56.39 | 0.94 | 12.98 |
Loss (Gain) From Sale of Investments | -99.77 | -99.77 | -411.59 | -3 | -19.98 | -20.93 |
Stock-Based Compensation | 26.46 | 26.46 | 6.97 | -6.28 | 2.54 | 11.42 |
Provision & Write-off of Bad Debts | -0.26 | -0.26 | -0.23 | -6.79 | 5.49 | 1.22 |
Other Operating Activities | -401.87 | -74.03 | -77.49 | -35.91 | 3.68 | -20.61 |
Change in Accounts Receivable | 23.78 | 23.78 | -60.93 | 15.4 | 107.1 | -258.94 |
Change in Inventory | -30.46 | -30.46 | -35.01 | 33.36 | - | - |
Change in Accounts Payable | 186.34 | 186.34 | 17.83 | 63.46 | 9.24 | -67.49 |
Change in Unearned Revenue | -15.64 | -15.64 | -7.09 | -5.46 | -10.49 | -18.83 |
Operating Cash Flow | 2,791 | 3,043 | 281.14 | 416.35 | 233.49 | -243.79 |
Operating Cash Flow Growth | 899.80% | 982.55% | -32.48% | 78.32% | - | - |
Capital Expenditures | -263.32 | -252.95 | -280.78 | -235.75 | -221.26 | -263.82 |
Sale of Property, Plant & Equipment | - | - | 0.69 | 100.45 | 0.4 | 0.38 |
Investment in Securities | -2,866 | -3,058 | -953.98 | -366.5 | -725.89 | 214 |
Other Investing Activities | 207.32 | 147.07 | 483.93 | 22.37 | 30.06 | 30.94 |
Investing Cash Flow | -2,922 | -3,164 | -750.14 | -479.42 | -916.69 | -18.5 |
Short-Term Debt Issued | - | - | 50 | 50 | 150 | - |
Total Debt Issued | - | - | 50 | 50 | 150 | - |
Short-Term Debt Repaid | - | -50 | -50 | -150 | - | - |
Total Debt Repaid | -50 | -50 | -50 | -150 | - | - |
Net Debt Issued (Repaid) | -50 | -50 | - | -100 | 150 | - |
Issuance of Common Stock | 15.39 | 15.39 | - | - | 2.3 | - |
Common Dividends Paid | -76.17 | -76.46 | -52.37 | -1.47 | -1.22 | - |
Financing Cash Flow | -110.78 | -111.07 | -52.37 | -101.47 | 151.08 | - |
Foreign Exchange Rate Adjustments | 3.2 | 4.67 | 0.28 | 2.27 | 1.47 | -0.17 |
Net Cash Flow | -238.47 | -226.53 | -521.1 | -162.27 | -530.66 | -262.47 |
Free Cash Flow | 2,527 | 2,791 | 0.35 | 180.61 | 12.23 | -507.61 |
Free Cash Flow Growth | 16578.80% | 787511.40% | -99.80% | 1376.67% | - | - |
Free Cash Flow Margin | 58.52% | 66.45% | 0.03% | 17.81% | 1.48% | -54.65% |
Free Cash Flow Per Share | 4.07 | 4.50 | 0.00 | 0.29 | 0.02 | -0.84 |
Cash Income Tax Paid | 212.58 | 44.26 | 43.1 | 29.24 | 24.57 | 21.75 |
Levered Free Cash Flow | -630.4 | 1,979 | -66.63 | 46.51 | -14.48 | -394.76 |
Unlevered Free Cash Flow | -630.22 | 1,979 | -65.9 | 47.38 | -13.66 | -394.76 |
Change in Working Capital | 166.83 | 166.83 | -68.94 | 134.03 | 69.1 | -381.39 |